Molecule of the month. Ruboxistaurin mesilate hydrate.
出版信息
Drug News Perspect. 2003 Dec;16(10):691.
PMID:14747848
Abstract
摘要
相似文献
1
Molecule of the month. Ruboxistaurin mesilate hydrate.
Drug News Perspect. 2003 Dec;16(10):691.
2
[Role of PKC in the pathogenesis of diabetic vascular complications].
Nihon Rinsho. 2002 Oct;60 Suppl 10:67-72.
3
Ruboxistaurin.
Drugs Today (Barc). 2006 Sep;42(9):577-85. doi: 10.1358/dot.2006.42.9.996566.
4
Ruboxistaurin, a protein kinase C beta inhibitor, as an emerging treatment for diabetes microvascular complications.鲁伯斯塔林，一种蛋白激酶Cβ抑制剂，作为糖尿病微血管并发症的新兴治疗方法。
Ann Pharmacother. 2005 Oct;39(10):1693-9. doi: 10.1345/aph.1E572. Epub 2005 Sep 13.
5
Ruboxistaurin for diabetic retinopathy.鲁比前列酮用于治疗糖尿病性视网膜病变。
Ophthalmology. 2006 Dec;113(12):2135-6. doi: 10.1016/j.ophtha.2006.09.003.
6
Ruboxistaurin mesilate hydrate for diabetic retinopathy.甲磺酸盐鲁比前列酮水合物用于治疗糖尿病性视网膜病变。
Drugs Today (Barc). 2009 Apr;45(4):269-74. doi: 10.1358/dot.2009.45.4.1354195.
7
[Protein kinase C beta-Inhibitor ruboxistaurin].[蛋白激酶Cβ抑制剂鲁比前列酮]
Med Monatsschr Pharm. 2005 Aug;28(8):292-3.
8
Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy.鲁比前列酮对糖尿病视网膜病变患者视力丧失的影响。
Ophthalmology. 2006 Dec;113(12):2221-30. doi: 10.1016/j.ophtha.2006.07.032. Epub 2006 Sep 20.
9
Effect of ruboxistaurin on urinary transforming growth factor-beta in patients with diabetic nephropathy and type 2 diabetes.鲁伯斯塔林对糖尿病肾病合并2型糖尿病患者尿转化生长因子-β的影响。
Diabetes Care. 2007 Apr;30(4):995-6. doi: 10.2337/dc06-2079. Epub 2007 Jan 17.
10
Effect of ruboxistaurin on the visual acuity decline associated with long-standing diabetic macular edema.鲁比前列酮对与长期糖尿病性黄斑水肿相关的视力下降的影响。
Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6890; author reply 6890-1. doi: 10.1167/iovs.09-4106.
引用本文的文献
1
Effects of chronic renal failure on the pharmacokinetics of ruboxistaurin and its active metabolite 338522.
Clin Pharmacokinet. 2006;45(3):297-303. doi: 10.2165/00003088-200645030-00005.
Zotero 插件